Affordable Access

Publisher Website

An audit of re-admission to intensive care after initial recovery from pulmonary resection: is it worthwhile?

Critical Care
Springer (Biomed Central Ltd.)
Publication Date
DOI: 10.1186/cc1807
  • Meeting Abstract
  • Education
  • Medicine


S1 Available online Critical Care Volume 6 Supplement 2, 2002 19th Spring Meeting of the Association of Cardiothoracic Anaesthetists: selected abstracts Cambridge, UK, 21 June 2002 Association of Cardiothoracic Anaesthetists Published online: 9 July 2002 This article is online at © 2002 BioMed Central Ltd (Print ISSN 1364-8535; Online ISSN 1466-609X) The publication of these abstracts was made possible by an unrestricted educational grant from Bayer plc 1 A survey of non-depolarising muscle relaxants used in cardiac anaesthesia and surgery S Briggs, R Thomas, P Goodyear, D Smith Department of Anaesthesia, Southampton University Hospitals NHS Trust, Tremona Road, Southampton SO16 6YD, UK Critical Care 2002, 6 (Suppl 2):1 Introduction: Residual neuromuscular blockade contributes to postoperative morbidity and mortality, and is more common with long-acting non-depolarising muscle relaxants (NDMRs) such as pancuronium [1]. This phenomenon may be a common occurrence in ‘fast-track’ managed cardiac patients administered long-acting NDMRs. We examine the usage of NDMRs in cardiac anaesthesia in the United Kingdom. Methods: A postal questionnaire was sent to 310 consultant cardiac anaesthetists in the United Kingdom. We asked which NDMRs are preferred (differentiating between ‘fast-track’ [FT] and ‘non-fast-track’ [NFT] management of patients), and what methods are used to assess neuromuscular function prior to extubation. Results: There was a 72.6% (225/310) response rate, of which 217 responses were valid. A single-agent NDMR technique is most prevalent for both NFT (92.2%) and FT patients (88.5%). Pancuronium (either as sole agent or in combination with another NDMR) was the first choice for NFT and FT patients, 73.7% and 52.1% respectively. For both management strategies, rocuronium is the next most popular agent. Benzylisoquinolinium derivatives are not in common usage. Forty-nine out of 211 anaesthetists (where

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times